Orchestra BioMed logo

Close

  • Who We Are
    • Our Approach
    • Our People
    • Careers
  • Our Innovations
    • Pipeline
    • Therapeutic Areas
    • Virtue® SAB
    • BackBeat CNT™
    • FreeHold Retractors
  • News & Events
  • Contact Us

Our Innovations

Pipeline

Advancing a multi-asset pipeline of high-impact therapeutic solutions

Our pipeline is comprised of innovative therapeutic products that have the potential for optimized value creation using our partnership-enabled business model.

SWIPE TO SCROLL swipe to scroll
Pipeline

Our flagship product candidates, Virtue SAB and BackBeat CNT, exemplify key criteria that characterize innovations optimized for strategic partnerships:

  • Target large therapeutic device markets with significant unmet needs
  • Provide high impact procedure-based solutions with rapid adoption potential
  • Offer strategic and financial benefits to commercial partners

*Minimally Invasive Surgical (MIS) solutions

Virtue® SAB is not approved for commercial use in the US

BackBeat CNT™ is not approved for commercial use in the US

Orchestra BioMed logo
  • Who We Are
    Our Approach
    Our People
    Careers
  • Our Innovations
    Pipeline
    Therapeutic Areas
    Virtue® SAB
    BackBeat CNT™
    FreeHold Retractors
  • News & Events
  • Contact Us

© 2021 Orchestra BioMed Inc. Virtue®, BackBeat CNT™ FreeHold Duo®, FreeHold Trio® and Orchestra BioMed™ are trademarks of Orchestra BioMed.
All other trademarks are trademarks of their respective owners.
SM-0020 Rev 01

Disclaimer